---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285246695.md"
description: "Clearmind Medicine shares are trading lower. The company announced filing of a European patent application for psychedelic compounds targeting the treatment of Post-Traumatic Stress Disorder and other mental health disorders."
datetime: "2026-05-05T17:53:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285246695.md)
  - [en](https://longbridge.com/en/news/285246695.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285246695.md)
---

# 

Clearmind Medicine shares are trading lower. The company announced filing of a European patent application for psychedelic compounds targeting the treatment of Post-Traumatic Stress Disorder and other mental health disorders.

### Related Stocks

- [CMND.US](https://longbridge.com/en/quote/CMND.US.md)

## Related News & Research

- [DoctorDerm Unveils Rebrand and Expands Platform with New Prescription Skin and Lash Treatments](https://longbridge.com/en/news/286923716.md)
- [Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD | CMND Stock News](https://longbridge.com/en/news/285210302.md)
- [Allworth Financial LP Grows Stake in Merck & Co., Inc. $MRK](https://longbridge.com/en/news/286522605.md)
- [Alaunos Reports Preclinical Aln1003 Data Showing Effects On Insulin-Resistance-Related Biomarkers And Liver Histology In Diet-Induced Obesity Models](https://longbridge.com/en/news/286776760.md)
- [Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline](https://longbridge.com/en/news/286673327.md)